Cargando…

Cardiovascular Effects of Autologous Bone Marrow–Derived Mesenchymal Stromal Cell Therapy With Early Tacrolimus Withdrawal in Renal Transplant Recipients: An Analysis of the Randomized TRITON Study

BACKGROUND: After renal transplantation, there is a need of immunosuppressive regimens that effectively prevent allograft rejection while minimizing cardiovascular complications. This substudy of the TRITON trial evaluated the cardiovascular effects of autologous bone marrow–derived mesenchymal stro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Meucci, Maria Chiara, Reinders, Marlies E. J., Groeneweg, Koen E., Bezstarosti, Suzanne, Ajmone Marsan, Nina, Bax, Jeroen J., De Fijter, Johan W., Delgado, Victoria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9075245/ https://www.ncbi.nlm.nih.gov/pubmed/34913362 http://dx.doi.org/10.1161/JAHA.121.023300

Ejemplares similares

Autologous bone marrow‐derived mesenchymal stromal cell therapy with early tacrolimus withdrawal: The randomized prospective, single‐center, open‐label TRITON study
por: Reinders, Marlies E. J., et al.
Publicado: (2021)

Autologous bone marrow derived mesenchymal stromal cell therapy in combination with everolimus to preserve renal structure and function in renal transplant recipients
por: Reinders, Marlies EJ, et al.
Publicado: (2014)

Peripheral Blood Immune Cell Composition After Autologous MSC Infusion in Kidney Transplantation Recipients
por: Hendriks, Sanne H., et al.
Publicado: (2023)

Safety and Efficacy Endpoints for Mesenchymal Stromal Cell Therapy in Renal Transplant Recipients
por: Bank, J. R., et al.
Publicado: (2015)

Characterizing mitral regurgitation in a contemporary population: prognostic implications
por: Delgado, Victoria, et al.
Publicado: (2019)

Safety of allogeneic bone marrow derived mesenchymal stromal cell therapy in renal transplant recipients: the neptune study
por: Reinders, Marlies E. J., et al.
Publicado: (2015)

Circulating Long Noncoding RNA LNC-EPHA6 Associates with Acute Rejection after Kidney Transplantation
por: Groeneweg, Koen E., et al.
Publicado: (2020)

Multi-Modality Imaging for Interventions in Tricuspid Valve Disease
por: Fortuni, Federico, et al.
Publicado: (2021)

Prospective Controlled Protocol for Three Months Steroid Withdrawal with Tacrolimus, Basiliximab, and Mycophenolate Mofetil in Renal Transplant Recipients
por: Oh, Chang-Kwon, et al.
Publicado: (2012)

Prognostic implications of left ventricular inward displacement assessed by cardiac magnetic resonance imaging in patients with myocardial infarction
por: Nabeta, Takeru, et al.
Publicado: (2023)

Hemodynamic implications of mitral annular calcification in patients undergoing transcatheter aortic valve implantation for severe aortic stenosis
por: Hirasawa, Kensuke, et al.
Publicado: (2023)

A Comprehensive Evaluation of the Antibody-Verified Status of Eplets Listed in the HLA Epitope Registry
por: Bezstarosti, Suzanne, et al.
Publicado: (2022)

Assessment of D-Shaped Annulus of Mitral Valve in Patients with Severe MR Using Semi-Automated 4-Dimensional Analysis: Implications for Transcatheter Interventions
por: Vo, N. Mai, et al.
Publicado: (2020)

Neptune and Triton
por: Cruikshank, D P
Publicado: (2016)

Diabetic nephropathy alters circulating long noncoding RNA levels that normalize following simultaneous pancreas–kidney transplantation
por: Groeneweg, Koen E., et al.
Publicado: (2020)

Human leukocyte antigen selected allogeneic mesenchymal stromal cell therapy in renal transplantation: The Neptune study, a phase I single‐center study
por: Dreyer, Geertje J., et al.
Publicado: (2020)

Left atrial dysfunction is an independent predictor of mortality in patients with cirrhosis treated by transjugular intrahepatic portosystemic shunt
por: Meucci, Maria Chiara, et al.
Publicado: (2022)

Cell-free DNA measurement of three genomes after allogeneic MSC therapy in kidney transplant recipients indicates early cell death of infused MSC
por: Dreyer, Geertje J., et al.
Publicado: (2023)

Clinical Implications of Tacrolimus Time in Therapeutic Range and Intrapatient Variability in Urban Renal Transplant Recipients Undergoing Early Corticosteroid Withdrawal
por: Pierce, Dana R., et al.
Publicado: (2021)

Right Ventricular Reverse Remodeling After Tricuspid Valve Surgery for Significant Tricuspid Regurgitation
por: Galloo, Xavier, et al.
Publicado: (2022)

Determinants and prognostic implications of left ventricular mechanical dispersion in aortic stenosis
por: Prihadi, Edgard A, et al.
Publicado: (2019)

QRS duration versus morphology and survival after cardiac resynchronization therapy
por: Khidir, Mand J.H., et al.
Publicado: (2016)

On the origin of Triton and Pluto
por: McKinnon, William B.
Publicado: (1984)

A population pharmacokinetic model to predict the individual starting dose of tacrolimus in adult renal transplant recipients
por: Andrews, L. M., et al.
Publicado: (2019)

Severe COVID-19 in a renal transplant recipient: A focus on pharmacokinetics
por: Meziyerh, Soufian, et al.
Publicado: (2020)

Association between computed tomography-derived tricuspid annular dimensions and prognosis: insights from whole-beat computed tomography assessment
por: Hirasawa, Kensuke, et al.
Publicado: (2021)

Comparative analysis of right ventricular strain in Fabry cardiomyopathy and sarcomeric hypertrophic cardiomyopathy
por: Meucci, Maria Chiara, et al.
Publicado: (2022)

Tacrolimus trough levels in kidney transplant recipients
por: Hwang, Young Hui, et al.
Publicado: (2021)

Left ventricular inflow propagation velocity for diastolic function testing: head-to-head comparison between velocity-encoded MRI and color M-mode Doppler echocardiography
por: van den Boogaard, Pieter J, et al.
Publicado: (2013)

Force transduction by Triton cytoskeletons
por: Sawada, Yasuhiro, et al.
Publicado: (2002)

Tricuspid regurgitation after cardiac resynchronization therapy: evolution and prognostic significance( )
por: Stassen, Jan, et al.
Publicado: (2022)

Valvular heart disease: shifting the focus to the myocardium
por: Ajmone Marsan, Nina, et al.
Publicado: (2022)

Mesenchymal Stromal Cell-Based Therapy
por: Mönch, Dina, et al.
Publicado: (2023)

A Randomized Pharmacokinetic Study of Generic Tacrolimus Versus Reference Tacrolimus in Kidney Transplant Recipients
por: Alloway, R R, et al.
Publicado: (2012)

Pharmacokinetics of apixaban and tacrolimus or cyclosporine in kidney and lung transplant recipients
por: Mansell, Holly, et al.
Publicado: (2022)

Body composition is associated with tacrolimus pharmacokinetics in kidney transplant recipients
por: Francke, M. I., et al.
Publicado: (2022)

Sex differences in prognosis of significant secondary mitral regurgitation
por: Namazi, Farnaz, et al.
Publicado: (2021)

Clinical Pharmacokinetics of Tacrolimus in Iranian Liver Transplant Recipients
por: Nasiri-Toosi, Zahra, et al.
Publicado: (2014)

Gout Due to Tacrolimus in a Liver Transplant Recipient
por: Afridi, Summia Matin, et al.
Publicado: (2019)

Interaction between secondary mitral regurgitation and left atrial function and their prognostic implications after cardiac resynchronization therapy
por: Stassen, Jan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ml3qd82a6mcchsaafrgkj2t74a